Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128802 · ClinicalTrials.gov registry record · NA
Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure
A NA study of Renal Failure and Severe Obesity, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02128802 is a NA study of Renal Failure and Severe Obesity that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 20 participants, below the 300-participant average among 11 other Renal Failure trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02128802, a NA study of Renal Failure and Severe Obesity, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.
Conditions Studied
Interventions
- PROCEDURE Gastric Bypass
- OTHER Weight Loss Program
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2024-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02128802
The ClinicalTrials.gov registry entry for NCT02128802 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 300-participant average among 11 other Renal Failure trials with a reported enrollment target (93% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Renal Failure appearing as the primary indexed condition, and to 2 interventions - of which Gastric Bypass is the first listed.
NCT02128802 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT02128802 about?
NCT02128802 is a clinical study titled "Obesity Surgery and Kidney Transplant for Patients With Obesity and Renal Failure". Gastric Bypass followed by renal transplantation is superior to medical management followed by renal transplant for patients with severe obesity and renal failure.
What is the current status of trial NCT02128802?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-04-01. Estimated completion is 2024-03-28.
What conditions does trial NCT02128802 study?
This clinical trial studies the following conditions: Renal Failure, Severe Obesity.
What interventions are being tested in trial NCT02128802?
The interventions under investigation include: Gastric Bypass (PROCEDURE), Weight Loss Program (OTHER).
Who is sponsoring clinical trial NCT02128802?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02128802 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Post-Filter Hematocrit
RECRUITING · NA
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Improving Patient Prioritization During Hospital-homecare Transition
COMPLETED · NA
-
Pilot Study Dara-CyBorD in Newly Diagnosed Multiple Myeloma Patients With Renal Failure
RECRUITING · Early Phase 1
-
Prevent Cardiac Surgery Associated AKI Trial
RECRUITING · Phase 2
-
Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.